Quick Answer
CHAMPIONS ONCOLOGY, INC. reported Research And Development Expense of $6.83 million for the year ending 2025.
- CHAMPIONS ONCOLOGY, INC. showed a decrease of -28.5% in Research And Development Expense from 2024 to 2025.
- This data is from CHAMPIONS ONCOLOGY, INC.'s annual report (Form 10-K), filed with the SEC on July 23, 2025.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 15 years of available data (2011 to 2025), CHAMPIONS ONCOLOGY, INC.'s Research And Development Expense has grown by 134.5%.
- Historical annual values: Fiscal year 2025: $6.83 million | Fiscal year 2024: $9.54 million | Fiscal year 2023: $11.55 million | Fiscal year 2022: $9.37 million | Fiscal year 2021: $7.20 million | Fiscal year 2020: $5.85 million | Fiscal year 2019: $4.80 million | Fiscal year 2018: $4.40 million | Fiscal year 2017: $4.29 million | Fiscal year 2016: $4.19 million | Fiscal year 2015: $4.85 million | Fiscal year 2014: $2.27 million | Fiscal year 2013: $1.92 million | Fiscal year 2012: $2.94 million | Fiscal year 2011: $2.91 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: